HeartSciences Inc. (HSCS)
$3.09-6.36%Close
SELLCRISIS · day 11
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $7M
- Beta
- 1.77
- P/E (TTM)
- -0.97
- Short % float
- 1.43%
- Days to cover
- 1.0
- SI change
- -29.9%
- 1W
- -18.04%
- 1M
- -12.71%
- vs SPY 1W
- -17.90%
- vs SPY 1M
- -15.22%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 0
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-730.1%
REV YoY-
ROE-1216.9%
EPS YoY-
ROA-274.5%
GROSS-2909
OP-209733
NET-227024
[VALUATION]
P/E TTM-0.97
P/E FWD-
SECTOR PE20.34
INDUSTRY PE22.66
P/B-5.58
P/FCF-
EV/EBITDA2.06
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO0.12
ND/EBITDA-
BETA1.77
NET INCOME (TTM) < 0
Company news
FAQ
- What is LOPJLB’s current signal on HSCS?
- LOPJLB’s latest quantitative signal on HeartSciences Inc. (HSCS) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is HSCS in?
- HeartSciences Inc. (HSCS) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does HeartSciences Inc. (HSCS) do?
- HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural agin…